Substituted benzenecarboxamides as IL-17A modulators
申请人:DiCE Alpha, Inc.
公开号:US11274094B2
公开(公告)日:2022-03-15
The disclosure herein provides compounds and pharmaceutical compositions for the modulation of IL-17A useful for the treatment of inflammatory conditions, such as psoriasis.
The disclosure herein provides compounds and pharmaceutical compositions for the modulation of IL-17A useful for the treatment of inflammatory conditions, such as psoriasis.